PBM

Propel Bio Management Portfolio holdings

AUM $82.4M
1-Year Est. Return 29.33%
This Quarter Est. Return
1 Year Est. Return
+29.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$86.1M
AUM Growth
-$14.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
23
New
Increased
Reduced
Closed

Top Buys

1
+$2.04M
2
+$1.16M
3
+$909K
4
APLT icon
Applied Therapeutics
APLT
+$816K
5
CMPX icon
Compass Therapeutics
CMPX
+$434K

Top Sells

1
+$4.82M
2
+$4.65M
3
+$4.31M
4
KYMR icon
Kymera Therapeutics
KYMR
+$2.27M
5
KURA icon
Kura Oncology
KURA
+$1.13M

Sector Composition

1 Healthcare 67.17%
2 Energy 31.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAGP icon
1
Plains GP Holdings
PAGP
$3.35B
$27.2M 31.57%
1,272,360
MDGL icon
2
Madrigal Pharmaceuticals
MDGL
$9.85B
$9.95M 11.56%
30,032
-13,000
AKRO icon
3
Akero Therapeutics
AKRO
$4.3B
$9.27M 10.76%
228,884
-114,845
PHAT icon
4
Phathom Pharmaceuticals
PHAT
$944M
$7.12M 8.27%
1,134,927
+145,000
ACHV icon
5
Achieve Life Sciences
ACHV
$157M
$6.55M 7.61%
2,453,092
APLT icon
6
Applied Therapeutics
APLT
$180M
$5.52M 6.41%
11,285,420
+1,670,000
RNA icon
7
Avidity Biosciences
RNA
$7.12B
$5.27M 6.12%
178,500
ABEO icon
8
Abeona Therapeutics
ABEO
$280M
$2.97M 3.45%
624,022
TCRX icon
9
TScan Therapeutics
TCRX
$141M
$2.88M 3.35%
2,087,139
DCTH icon
10
Delcath Systems
DCTH
$432M
$2.26M 2.63%
177,600
+160,600
SNDX icon
11
Syndax Pharmaceuticals
SNDX
$1.3B
$2.25M 2.62%
183,259
ZVRA icon
12
Zevra Therapeutics
ZVRA
$639M
$1.35M 1.57%
179,874
MIST icon
13
Milestone Pharmaceuticals
MIST
$167M
$1.16M 1.35%
+1,451,557
CMPX icon
14
Compass Therapeutics
CMPX
$776M
$434K 0.5%
+228,317
ATHA icon
15
Athira Pharma
ATHA
$14.4M
$425K 0.49%
1,492,792
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$423K 0.49%
146,381
ARDX icon
17
Ardelyx
ARDX
$1.22B
– –
-950,947
CMPS
18
Compass Pathways
CMPS
$615M
– –
-25,209
JSPR icon
19
Jasper Therapeutics
JSPR
$69.3M
– –
-20,000
KURA icon
20
Kura Oncology
KURA
$879M
– –
-130,000
KYMR icon
21
Kymera Therapeutics
KYMR
$4.32B
– –
-56,359